AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
DIAZEPAM in Zimbabwe
5 products registered with MCAZ — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| DOVAL TABLET; ORAL | 2025/13.2.2/6950 | INNOVATA PHARMACEUTICALS | active | 7 May 2030 |
| DIZAM TABLET; ORAL | 77/13.02.02/944 | CAPS INTERNATIONAL EST | active | 31 Dec 2027 |
| DIZAM INJECTABLE; INJECTION | 73/13.02.02/0130 | CAPS PVT LTD | active | 31 Dec 2027 |
| DIAZEPAM TABLET; ORAL | 89/13.2.2/2229 | WALLACE LABORATORIES PVT LTD | active | 31 Dec 2027 |
| PHARMA-Q DIAZEPAM INJECTABLE; INJECTION, AMPOULE | 98/13.2.2/3381 | PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS | active | 31 Dec 2027 |
DIAZEPAM — MCAZ Registration Details
MCAZ (Zimbabwe) has 5 registered products containing DIAZEPAM, of which 5 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track DIAZEPAM registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.